
Ackerman and Bunick review 52-week AMETHYST data for litifilimab in refractory cutaneous lupus and make the case for dermatology-led CLE care.
This Month in Review summary highlights various news highlights featured in February’s dermatology news coverage.
In the latest iteration of our Month in Review series, the HCPLive editorial team highlight a set of different news stories in the






